wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38817910-055B78AB-1D43-4208-ABAC-EC1DA1B81988
Q38817910-055B78AB-1D43-4208-ABAC-EC1DA1B81988
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38817910-055B78AB-1D43-4208-ABAC-EC1DA1B81988
Allosteric modulators of MEK1: drug design and discovery.
P2860
Q38817910-055B78AB-1D43-4208-ABAC-EC1DA1B81988
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38817910-055B78AB-1D43-4208-ABAC-EC1DA1B81988
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b7527d2839f52860a24b383ba6da815e1fa4ae7
P2860
Allosteric MEK1/2 inhibitor refametinib (BAY 86-9766) in combination with sorafenib exhibits antitumor activity in preclinical murine and rat models of hepatocellular carcinoma.